The higher expression of components of STAT4‐related pathway and Srps in the responder cohort than in non‐responder cases was observed, respectively, with a consistent trend among seven immune activation biomarkers30 (Figure 5A), suggesting high‐Srps cases had more “hot” tumor environment than patients with low Srps levels.31 Here, STAT4 is linked to neoplasm.